Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02413866 · ClinicalTrials.gov registry record · NA
Weight Outlooks by Restriction of Diet and Sleep
A NA study of Weight, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02413866: Completed NA study of Weight, sponsored by University of South Carolina.
NCT02413866 is a NA study of Weight that has completed, run by University of South Carolina. The registered enrollment target is 36 participants, below the 381-participant average among 5 other Weight trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02413866, a NA study of Weight, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine whether chronic moderate sleep restriction effects the amount of body fat and lean mass loss, and calorie expenditure, in individuals who are participating in a dietary weight loss program.
Primary Outcome
Body composition will be measured via DXA scans prior to intervention and post intervention to compare losses in lean body mass and fat mass.
Conditions Studied
Interventions
- BEHAVIORAL Calorie restriction only
- BEHAVIORAL Sleep & calorie restriction
Study Locations (1)
South Carolina
- University of South Carolina - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT02413866 record still lists
NCT02413866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 381-participant average among 5 other Weight trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Weight appearing as the primary indexed condition, and to 2 interventions - of which Calorie restriction only is the first listed.
NCT02413866 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT02413866 about?
NCT02413866 is a clinical study titled "Weight Outlooks by Restriction of Diet and Sleep". The purpose of this study is to examine whether chronic moderate sleep restriction effects the amount of body fat and lean mass loss, and calorie expenditure, in individuals who are participating in a dietary weight loss program.
What is the current status of trial NCT02413866?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2015-01. Estimated completion is 2016-11.
What conditions does trial NCT02413866 study?
This clinical trial studies the following conditions: Weight.
What interventions are being tested in trial NCT02413866?
The interventions under investigation include: Calorie restriction only (BEHAVIORAL), Sleep & calorie restriction (BEHAVIORAL).
Who is sponsoring clinical trial NCT02413866?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02413866 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Addressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial
RECRUITING · NA
-
A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer
COMPLETED · NA
-
Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate
COMPLETED · NA
-
PaTH Clinical Data Research Network (CDRN) Study of Healthy Lifestyles and Health Care
ACTIVE NOT RECRUITING
-
A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia